Amsterdam institute for Immunology and Infectious Diseases is supported in its valorisation activities by the IXA AI&I business development team:
Dilek Yusuf
Pieter Slijkerman
Wim Meijberg
The business development team comprises three members, with Dilek Yusuf dedicated full-time to AI&I, while Pieter Slijkerman and Wim Meijberg, allocate their focus across multiple research institutes.
Innovation Exchange Amsterdam (IXA)
Innovation Exchange Amsterdam (IXA) serves as the valorization center for Amsterdam UMC, Vrije Universiteit Amsterdam (VU), University of Amsterdam (UvA), and Amsterdam University of Applied Sciences (HvA). IXA offers comprehensive support throughout the entire valorization process, helping you pinpoint the optimal strategy for your innovation or technology.
IXA's services encompass everything from patenting inventions and negotiating research and licensing agreements with industry partners to facilitating the establishment of startup companies based on UMC technologies and negotiating research collaborations with industry leaders.
Learn more here.
When to reach out to the Business Development team?
Feel free to contact the AI&I Business Development team for inquiries related to:
- Collaborating with private partners;
- Seeking private partners (e.g. Public-Private Partnership = PPP grants)
- Intellectual property
- Contract research services
- Valorization/impact strategy (e.g. in grant proposals)
Valorization Compass to Increase Societal Impact
Newsitem AI&I Business Development Team - 20.11.2024:
Do you have (preliminary) research results you want to translate into practical applications? Want to know how to create societal impact with your research findings? Amsterdam UMC has developed a new tool to help you develop successful valorization activities: the Valorization Compass. It offers practical tools and insight into the valorization process.
Guide for Researchers: Confidentiality Disclosure Agreement (CDA)
Download AI&I Business Development Team - 13.09.2024:
Via the link below you can download the CDA guide for Amsterdam UMC researchers. This guide provides essential instructions for researchers at Amsterdam UMC on handling Confidentiality Disclosure Agreements (CDA) when collaborating with external partners. Researchers are responsible for managing these agreements but are not authorized to sign a CDA independently. Only division directors or the Board of Directors can officially sign on behalf of the Amsterdam UMC.
The below guide outlines two scenarios:
1. If an external party provides the CDA, researchers must ensure it meets specific criteria such as governing law and confidentiality terms.
2. If using the Amsterdam UMC CDA template, researchers should customize and submit it for signatures.
Research Network Relaunched as Human Research Network
Newsitem AI&I Business Development Team - 09.09.2024:
The previously established Research Network (Research Netwerk) has been revitalized and rebranded as the 'Human Research Network' (Netwerk Mensgebonden Onderzoek - NMO). This platform is designed to foster collaboration and knowledge exchange among professionals involved in human-centered research. It also provides opportunities to host guest speakers who can address specific research topics.
TKI Subsidy for Collaborative Research Projects
Newsitem AI&I Business Development Team - 04.04.2024: Amsterdam UMC has secured a significant Translational Knowledge Institute (TKI) subsidy through Health~Holland. This funding can be used for collaborative research projects with industrial partners under the Public Private Partnership (PPP) framework. Prospective applicants are advised to initiate discussions with potential partners early on to streamline the proposal preparation process.
Collaboration with Inospin
Newsitem AI&I Business Development Team - 04.03.2024: The AI&I Business Development team has been in contact with the company Inospin and they have presented a new tool: PubCompare.ai, a search engine for methods and protocols.
PubCompare.ai is to protocol search what PubMed and Web of Science are to abstracts, featuring advanced keyword and semantic search functionalities for intelligent contextual comparisons.
The platform currently hosts a vast repository, referencing over 27 million methods sourced from Open Access papers, preprints, and Patents. Impressively, it covers approximately 75 to 90% of papers cited in PubMed (coverage may vary based on queries).
For those eager to explore this powerful tool, claim your free account or request additional information by contacting Antoine Mahe (antoine.mahe@inospin.com).
Learn more about our Business Development team in this article.
You can reach out to your dedicated business developer directly or contact the general emailaddress (ixa_aii@amsterdamumc.nl).